Richard S. Buller, Ph.D. [ contact information ]
Research Assistant Professor of Pediatrics;
Assistant Director Molecular Virology Laboratory
Dr. Buller received his Ph.D. in microbiology from the University of
Montana after which he completed an NIH postdoctoral fellowship
working in the Laboratory of Persistent Viral Diseases. After
finishing a post doctoral fellowship in clinical and public health
microbiology at Washington University he joined the Division of
Laboratory Medicine in the Department of Pediatrics at Washington
University where he currently is the Assistant Director of the
Molecular Diagnostics Laboratory.
Dr. Buller's research interests center on the use of molecular
biology techniques to detect infectious disease agents in clinical
specimens. Of particular interest are agents causing central
nervous system infections, infections due to cytomegalovirus, and
tick-borne infections.
Education
- B.S., Michigan Technological University
- M.S., Michigan Technological University
- Ph.D., University of Montana, 1983
Training
- Staff Fellow, NIH, NIAID, Laboratory of Persistent Viral Diseases at Rocky Mountain Laboratories, 1984-1989
- Postdoctoral fellow, clinical and public health microbiology,
Department of Pediatrics, Washington University School of Medicine, 1989-1991
Selected Publications
Roberts TC, Buller RS, Gaudreault-Keener M, Sternhell
KE, Garlock K, Singer GG, Brennan DC, Storch GA:
Effects
of storage temperature and time on qualitative and
quantitative detection of cytomegalovirus in blood
specimens by shell vial culture and PCR.
J Clinical Microbiology
1997;
35:2224-2228.
Brennan DC, Garlock KA, Singer GG, Schnitzler MA,
Lippmann JB, Buller RS, Gaudreault-Keener M, Lowell JA,
Shenoy S, Howard TK, Storch GA:
Prophylactic oral
ganciclovir compared to deferred therapy for control of
cytomegalovirus-disease in renal transplant recipients.
Transplantation
1997;
64:1843-1846.
Roberts TC, Brennan DC, Buller RS, Gaudreault-Keener M,
Schnitzler MA, Sternhell KE, Garlock KA, Singer GG,
Storch GA:
Quantitative PCR to predict occurrence of symptomatic cytomegalovirus (CMV) infection and assess response to ganciclovir therapy in renal transplant recipients.
J Infect Dis
1998;
178:626-635.
Buller RS, Arens M, Hmiel SP, Paddock CD, Sumner JW,
Rikihisa Y, Unver A, Gaudreault-Keener M, Manian FA,
Liddell AM, Schmulewitz N, Storch GA:
Ehrlichia ewingii,
a newly recognized agent of human ehrlichiosis.
N Engl J Med
1999;
341:148-155.
Young PP, Buller RS, Storch GA:
Evaluation of a
commercial DNA enzyme immunoassay for detection of
enterovirus RT-PCR reaction products amplified from
cerebrospinal fluid specimens.
J Clin Microbiol
2000;
38:4260-4261.
Buller RS (Storch
GA, ed.):
Specimen Collection and Transport.
Essentials of Diagnostic Virology
Churchill Livingstone, New York, 1999;
pp 25-36.
Buller RS (Storch GA, ed.):
Discovery of New Viral Pathogens.
Essentials of Diagnostic Virology
Churchill Livingstone, New York, 1999;
pp 309-318.
|
SCHOOL OF MEDICINE
